Alexander D Egorov (Alexander Egorov)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Inflammatory Response

Diabetic Retinopathy

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Stanislav Boychenko, Vera S Egorova, Andrew Brovin, Alexander D Egorov
White-to-Beige and Back: Adipocyte Conversion and Transcriptional Reprogramming. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Stanislav Boychenko, Vera S Egorova, Andrew Brovin, Alexander D Egorov
White-to-Beige and Back: Adipocyte Conversion and Transcriptional Reprogramming. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Alima Galieva, Alexander D Egorov, Alexander Malogolovkin, Andrew Brovin, Alexander V Karabelsky
RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. International journal of molecular sciences 25 (1) (2023)
Alima Galieva, Alexander D Egorov, Alexander Malogolovkin, Andrew Brovin, Alexander V Karabelsky
RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. International journal of molecular sciences 25 (1) (2023)
Anastasia Ryapolova, Ekaterina Minskaia, Nizami Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D Egorov, Victor Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Elena Subcheva, Alexander Malogolovkin, Roman A Ivanov, Alexander V Karabelsky
Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International journal of molecular sciences 25 (1) (2023)
Anastasia Ryapolova, Ekaterina Minskaia, Nizami Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D Egorov, Victor Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Elena Subcheva, Alexander Malogolovkin, Roman A Ivanov, Alexander V Karabelsky
Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International journal of molecular sciences 25 (1) (2023)
Anastasia Ryapolova, Ekaterina Minskaia, Nizami Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D Egorov, Victor Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Elena Subcheva, Alexander Malogolovkin, Roman A Ivanov, Alexander V Karabelsky
Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International journal of molecular sciences 25 (1) (2023)
Alima Galieva, Alexander D Egorov, Alexander Malogolovkin, Andrew Brovin, Alexander V Karabelsky
RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. International journal of molecular sciences 25 (1) (2023)
Alexander Malogolovkin, Nizami Gasanov, Alexander D Egorov, Marianna Weener, Roman Ivanov, Alexander V Karabelsky
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. Viruses 13 (7) (2021)